C.F. Singer
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- PARP inhibition in cancer therapy
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 2
-
- Advanced Breast Cancer Therapies 5
- Brain Metastases and Treatment 2
- Co-authors
- Vesna Bjelic‐Radisic (3 shared papers)Peter Schrenk (3 shared papers)Mohamed Mamdouh Salama (2 shared papers)A. Fink-Retter (2 shared papers)Daphne Gschwantler‐Kaulich (2 shared papers)Brigitta Dampier (1 shared paper)Swen Langer (1 shared paper)Gernot Hudelist (1 shared paper)
- Journals
- Annals of Oncology (4 papers)ESMO Open (2 papers)European Journal of Surgical Oncology (1 paper)British Journal of Cancer (1 paper)BMC Cancer (1 paper)
- Partner nations
- AustriaUnited StatesCanada
In The Last Decade
C.F. Singer
13 papers receiving 336 citations
Peers
Comparison fields: 5 of 45
- Cancer Research 75
- Oncology 99
- Pathology and Forensic Medicine 57
- Genetics 79
- Surgery 79
Countries citing papers authored by C.F. Singer
This map shows the geographic impact of C.F. Singer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.F. Singer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.F. Singer more than expected).
Fields of papers citing papers by C.F. Singer
This network shows the impact of papers produced by C.F. Singer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.F. Singer. The network helps show where C.F. Singer may publish in the future.
Co-authors
The 25 scholars most cited alongside C.F. Singer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 114 | |
| 2 | 2016 | 65 | |
| 3 | Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters. | 2006 | 50 |
| 4 | 2020 | 32 | |
| 5 | 2022 | 29 | |
| 6 | 2022 | 14 | |
| 7 | 2017 | 13 | |
| 8 | 2024 | 11 | |
| 9 | 2014 | 9 | |
| 10 | 2022 | 3 | |
| 11 | 2018 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2025 | 1 |
About C.F. Singer
C.F. Singer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Surgery, having authored 13 papers that have together received 344 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (4 papers), Breast Implant and Reconstruction (2 papers), Brain Metastases and Treatment (2 papers), BRCA gene mutations in cancer (2 papers), HER2/EGFR in Cancer Research (2 papers), Patient Satisfaction in Healthcare (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Cancer Research (75 citations), Oncology (99 citations), Pathology and Forensic Medicine (57 citations), Genetics (79 citations) and Surgery (79 citations). C.F. Singer has collaborated with scholars based in Austria, United States and Canada. Frequent co-authors include Vesna Bjelic‐Radisic, Peter Schrenk, Mohamed Mamdouh Salama, A. Fink-Retter, Daphne Gschwantler‐Kaulich, Brigitta Dampier, Swen Langer, Gernot Hudelist, Ernst Kubista and Hubert Pehamberger. Their work appears in journals such as Annals of Oncology, ESMO Open, European Journal of Surgical Oncology, British Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.